Surgery for Parkinson’s Disease: Focus on Deep Brain Stimulation Ramón L Rodríguez, MD Director of Clinical Services University of Florida Movement Disorders.

Slides:



Advertisements
Similar presentations
MOTOR NEURON DISEASE The motor neuron diseases (or motor neuron diseases) (MND) are a group of neurological disorders that selectively affect motor neurons.
Advertisements

Surgical management: DBS and effects on gait, posture and falls overview Miguel Coelho, MD Neurology Department, Hospital Santa Maria Clinical Pharmacology.
Evaluation of Movement Disorders
Parkinson’s Disease (PD)
The PARticulars of Parkinson’s Disease
Parkinson’s Disease Dr Rachel Cary, Warwick Hospital.
By Lisa Rosenberg Deep Brain Stimulation. Electrical probe implanted in brain Approved by FDA in mid 1990’s Hidden under skin Does not damage healthy.
DBS on Parkinson’s Disease By: Christopher Ross DeSanto BME 181 / February 11, 2010.
Paul Short, Ph.D. The Parkinson’s Coach NEUROPSYCHOLOGY OF PARKINSON’S COMMUNICATION PROBLEMS.
Surgery For Parkinson’s Disease Current Practice and Future Directions
Electrical stimulation of the brain: Deep Brain Stimulation (DBS)
Deep Brain Stimulation For parkinson’s disease
Erica Partridge Parkinson’s Disease. Definition Aetiology PD vs Parkinsonism Symptoms and signs Differentials Investigations Management Prognosis.
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
931-4 Convergence Insufficiency. History A 73-year old man with known PD for 10 years, complained of horizontal double vision for 18 months. He could.
Parkinson ’ s disease. Function Anatomy of Parkinson ’ s Disease.
TECHNOLOGY IN REHABILITATION
Parkinson’s Disease By Devin Cornford
Deep Brain Stimulation (DBS) Ramin AmirNovin, MD LDR Neurosurgery and Associates.
The Surgical Treatment of Parkinson’s Disease
Duodenal Levodopa Treatment in advanced Parkinson’s Disease
Parkinson’s Plus By: Glen Estrosos.
Treatment of Parkinson’s Disease Thomas L. Davis, M.D. Associate Professor of Neurology Vanderbilt School of Medicine.
Joohi Jimenez-Shahed, MD Assistant Professor of Neurology Baylor College of Medicine 8 th Annual IMHO Convention April 30, 2011 – Houston, TX Parkinson’s.
Alzheimer’s Disease The most common cause of Dementia –Progressive Memory Loss Plus loss in one other area of cognition: Perception Attention Language/Symbols.
BY: MACKENZIE SOARES ALYSSA MEDIEROS STEPHANIE GARDNER Parkinson's Disease.
PhD MD MBBS Faculty of Medicine Al Maarefa Colleges of Science & Technology Faculty of Medicine Al Maarefa Colleges of Science & Technology Lecture – 9:
Adult Medical-Surgical Nursing Neurology Module: Parkinson’s Disease.
Treatment of Parkinson Disease David Tran, 2013 Mercer University PharmD Candidate.
Mostly Parkinson’s disease but also few other movement disorders due to diseases of the basal ganglia.
Benjamin L. Walter M.D. Medical Director, Deep Brain Stimulation Program Neurological Institute University Hospitals Case Medical Center Management of.
BRAIN PACEMAKERS Madison Moreau BME 281 September 26, 2012.
Quantitative Detection of Parkinson's Disease Symptoms Advisor: Dr. Chris Kao Project Team: Kylen Bares Eddie Cao.
 Parkinson Disease (PD) is a disorder of the brain that causes a variety of movement problems.
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
 Parkinson’s Disease (PD) -progressive neurodegenerative disease affecting motor ability -third most common neurologic disorder of older adults.
Quantitative Detection of Parkinson's Disease Symptoms Advisor: Dr. Chris Kao Project Team: Kylen Bares Eddie Cao.
Sarah Ehlers & Brendan Valentine Parkinson’s Disease.
SYMPTOMS: Tremors, stiff muscles Shuffling gait, Poor coordination Balance problems, Fatigue Speech & swallowing difficulties TREATMENTS: Medications.
Neurological Disorders
second most common neurodegenerative disorder progressive loss of muscle control trembling of the limbs and head while at rest stiffness, slowness, and.
By Katelyn Chaimson and Sean Guyot
Parkinson's disease By Colby Allen. symptoms Mild to major tremors. Rigidity or joint stiffness Bradykinesia or slowness of movement Postural instability.
Parkinson’s Disease Angela Duncan June Why I Chose This Subject Common neurodegenerative disorder / in Scotland Expected increase.
Parkinson’s Disease Sheila Mulhern. Parkinson’s Disease Stats (PDF)  One million Americans live with Parkinson's disease, - more than the combined number.
 Parkinson Disease (PD) is a progressive disorder of the central nervous system that often impairs the sufferer's motor skills, speech, and other functions.
Parkinson’s Test Device Development Tiffany Feltman Erin Sikkel.
Pathogenesis and pathology of parkinsonism
Neurotransmitters in the brain By Joon Kim. Neurotransmitters  A neurotransmitter is a specialized messenger chemical that transfers or sends information.
Do Now 2/9/15 1.Describe possible causes for forgetting a memory. 2.Compare and contrast semantic and episodic memories.
Emma Hahs, Brooke Armistead, Sarah Brown, Sok Kean Khoo Department of Cell and Molecular Biology, College of Liberal Arts and Sciences, Grand Valley State.
How is Parkinson’s disease Diagnosed? And What Are the Treatment options?
Parkinson's disease ♦ Is a neurodegenerative disorder ♦ Develops around age 50 * incidence rises with age * affects 1-2% of population > age 65 ♦ Higher.
PARKINSON’S DISEASE CHAMINDA UNANTENNE RN,MS,MSN.
“HEALTH IS THE BEST” In the name of God. WHAT IS IT? Parkinson's disease (PD) is a chronic and progressive movement disorder, meaning that symptoms.
Deep Brain Stimulation: A Proven Treatment for Movement Disorders
Understanding Parkinsons Disease
Falon Fiorillo & Breeanna Fournier
Prediction of Parkinson’s Disease Tremor Onset Using Artificial Neural Networks Kevin Warwick.
“The effects of chronic changes to the functioning of the nervous system due to interference to neurotransmitter function, illustrated by the role of Dopamine.
Parkinson’s disease.
Parkinson's disease Parkinson's disease (PD) is the second-most common
Motor Fluctuations in Parkinson Disease: Options and Strategies
Parkinson Disease:.
Quantitative Detection of Parkinson's Disease Symptoms
Lucas McDuff and Meghan Mumpower
WHAT I NEED TO KNOW AS A PATIENT AND A CAREGIVER
Advanced Parkinson Disease: Are We Breaking New Ground?
Lucas McDuff and Meghan Mumpower
Deep Brain Stimulation: What, When, Why, How
Presentation transcript:

Surgery for Parkinson’s Disease: Focus on Deep Brain Stimulation Ramón L Rodríguez, MD Director of Clinical Services University of Florida Movement Disorders Center

Parkinson’s Disease Progressive neurodegenerative disease Affects the substantia nigra, which produces dopamine As a result, the patient develops the four cardinal symptoms of PD: Resting tremor, slowness, stiffness and balance problems

Parkinson’s Disease Shows a good response to levodopa (Sinemet) Medications help improves the cardinal symptoms of the disease Patients derive great benefit from the medication for a period of 5-7 years

Parkinson’s Disease With time, patients may develop motor fluctuations or side effects induced by levodopa This motor fluctuations may become the most disabling aspect of the disease

Parkinson’s Disease Wearing off Unpredictable off Sudden off Dose failures On-Off fluctuations

Parkinson’s Disease Levodopa induced Dyskinesias Diphasic Dyskinesias Peak dose Dyskinesias Levodopa induced Dystonia

Parkinson’s disease Development of this symptoms may take the disease from a non disabling to a disabling state At this stage, medical management may be difficult and accompanied by undesirable side effects

Parkinson’s Disease What can be done at this stage?

Surgery for Parkinson’s Disease Pallidotomy Thalamotomy Subthalamotomy Deep Brain Stimualtion [DBS]

Terapia Activa

What is DBS? Deep Brain Stimulation Device similar to a pacemaker Provides an electrical discharge to specific brain area This stimulation modulates the brain signals that causes the symptoms of Parkinson’s disease

Deep Brain Stimulation Not a cure for PD Does not replaces medications for PD Does not alter the mechanism of action of medications

Deep Brain Stimulation Improves the cardinal symptoms of Parkinson’s disease Smooth out motor fluctuations Increase “on” time Prevents disabling “off” periods

Deep Brain Stimulation Reversible procedure Side effect profile much more benign than lesioning procedures Can be done bilaterally As the disease advances, it can be modified

Deep Brain Stimulation

Microelectrode Recording STN Border/SN 10sec 80ms Sagittal Section Through the Thalamus Border

Intraoperative somatosensory evoked responses Microelectrode Mapping

Deep Brain Stimulation

Requires patient commitment for programming 64,000 different combinations Patience from both patient and programmer

Deep Brain Stimulation Battery needs to be replaces every 3-6 years Potential Complications Infection Lead fracture Lead Migration Skin erosion Mood and Behavioral changes

Deep Brain Stimulation DBS is not for every patient Proper patient selection is critical for success Proper placement of the device is required for success

Who is the best candidate? Disabling motor fluctuations Significant proportion of day spent in disabling “off” state Symptoms improve with levodopa Patients suffering from disabling dyskinesias

Not ideal candidate Poor response to levodopa Cognitive deficits or dementia Hallucinations not related to medications Patients diagnosed with Parkinson’s plus syndromes (MSA, Lewy Body Disease, Corticobasal Degeneration, Progressive Supranuclear Palsy)

Thank You!!!